Foley Partner Stephen Maebius was quoted in an article that appeared in BioWorld Today on September 12, 2011 titled “Passage of Patent Reform Bill is Just the Beginning.” Maebius discusses the America Invents Act, a major patent reform bill which he identifies as a wide scope of change that is likely to develop for several years as the courts interpret the Act in future patent lawsuits. Regarding biotech, he views the Act’s extension of the prior use defense as a potential benefit to a company that is developing a product but is not the first to file. Maebius adds that the Supreme Court will still need to resolve issues such as patent eligibility, which were not addressed by the reform.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."